Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sorrento Therapeutics Inc
(NQ:
SRNE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sorrento Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Market Briefing For Tuesday, Sept. 14
September 14, 2021
Inflation and COVID are tied at the hip in this market and economic scenario. I assessed inflation as 'enduring and not transitory' all along, and where COVID comes into-play is as a 'spoiler' to...
Via
Talk Markets
Market Briefing For Tuesday, Sept. 7
September 06, 2021
Economists are too worried about what's happening under the hood of the economic engine; when they really should realize all that's needed will be effective treatments and better vaccines to 'fuel' the...
Via
Talk Markets
Market Briefing For Thursday, Sept. 2
September 02, 2021
Near parabolic uptrends exist for the S&P and the Nasdaq, encouraging bulls, who should know better regarding 'finalized phasing' of runs but there's no assurance of a repeat phase of similar moves...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Market Briefing For Wednesday, Sept. 1
September 01, 2021
Nuances and ambiguities dominate the market and even geopolitical scene at the moment. We are going to have hotter inflation than the Fed would like, but growth does matter, because we concurrently...
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Market Briefing For Wednesday, Aug.25
August 25, 2021
The stock market holds, pretty impressive ahead of 'virtual Jackson Hole', and it faded late in the day just as we thought likely for the late going.
Via
Talk Markets
Market Briefing For Tuesday, Aug. 31
August 31, 2021
Moderate selling was masked in Monday's market, and it's against a clear backdrop of a stretched market, and even month-end pension sales, related to clients of Goldman Sachs raising 13B. The strength...
Via
Talk Markets
Why Shares of Sorrento Therapeutics Jumped This Week
August 26, 2021
The clinical-stage biopharmaceutical company published promising news in two separate studies.
Via
The Motley Fool
Sorrento's mRNA COVID-19 Vaccine Shows Efficacy In Preclinical Study
August 26, 2021
Sorrento Therapeutics Inc (NASDAQ: SRNE) has announced preclinical results for its mRNA-based COVID-19 vaccine against SARS-CoV-2. STI-mRNA includes a proprietary designer Spike...
Via
Benzinga
Exposures
COVID-19
Market Briefing For Thursday, Aug. 26
August 26, 2021
Underperformance by many stocks, but few that are really in trouble, is reflective of rising complacency, while technicians are frustrated at the lack of breakouts or breakdowns. That's actually fine,...
Via
Talk Markets
Sorrento In-Licenses COVID-19 Targeted MPro Inhibitors
August 24, 2021
Sorrento Therapeutics Inc (NASDAQ: SRNE) has entered into an option agreement with The Texas A&M University System for exclusive rights to highly...
Via
Benzinga
Exposures
COVID-19
Vaccine Victory
August 24, 2021
Monday the US stock market moved into further robust mode fueled by official FDA approval of the Pfizer and BioNTech COVID-19 vaccines. Will the momentum last through to Thursday when the Fed's Jackson...
Via
Talk Markets
Topics
Economy
Exposures
COVID-19
Interest Rates
Product Safety
Market Briefing For Tuesday, Aug. 24
August 24, 2021
Suspended elevation of the S&P may be in-absence of any alternatives to do so, given what pretty much would be a 'snapping' of the short-term uptrend if that's broken.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?
August 23, 2021
If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the...
Via
Talk Markets
Exposures
Product Safety
Market Briefing For Monday, Aug. 23
August 23, 2021
We might be near a moment of truth for the Senior Indexes, either in just a few days or postponed until after Labor Day.
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
August 20, 2021
Gainers Geovax Labs (NASDAQ:GOVX) shares...
Via
Benzinga
Market Briefing For Tuesday, Aug. 17
August 17, 2021
Momentum grows for a Fed taper. Investor risk now is no more than just a couple weeks ago. Actually a Fed movement is a plus as it suggest they're a believe in economic growth; which will be favorable...
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Market Briefing For Monday, Aug. 16
August 16, 2021
Too many permabears are almost delirious with negativity and still give extremely bearish outlooks, when that's not a correct read of markets.
Via
Talk Markets
Week In Review: RemeGen Out-Licenses Rights For HER2 ADC To Seagen In $2.6 Billion Deal
August 14, 2021
Yantai's RemeGen out-licensed global rights (ex-Asia) for its novel HER2-targeted ADC to Seagen in a $2.6 billion deal. Seagen, an antibody conjugate company, will pay $200 million upfront and up to...
Via
Talk Markets
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
Why Dynavax, Novavax, and Sorrento Soared This Week
August 13, 2021
There were different reasons behind each of these COVID-19 vaccine stocks' big gains.
Via
The Motley Fool
Exposures
COVID-19
Market Briefing For Thursday, Aug. 12
August 12, 2021
Fear and hysteria are not engineered by Washington about COVID, however it is a 'mood' to factor into everything from media to stock market projections.
Via
Talk Markets
Dyadic Stock Jumps On Development Pact With Sorrento For Diagnostics & Therapies For Coronaviruses
August 11, 2021
Dyadic International Inc (NASDAQ: DYAI) and Sorrento Therapeutics Inc (NASDAQ: SRNE) have announced a binding term sheet for a License Agreement to...
Via
Benzinga
Market Briefing For Tuesday, Aug. 10
August 10, 2021
Most markets held gains as the total backdrop has not changed. Lots of money managers are eager to see a decline, to put more money 'in', but the market hasn't cooperated by dropping 'much'.
Via
Talk Markets
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
August 09, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Thinking About Buying Stock In AMD, General Motors Or Sorrento Therapeutics?
August 09, 2021
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I...
Via
Benzinga
Market Briefing For Monday, Aug. 9
August 09, 2021
Ultimately energy markets will envision post-pandemic era robust economic activity resuming, even though Covid surges temporarily squelch demand.
Via
Talk Markets
Cramer Advises Viewers On Palantir, SoFi And More
August 04, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer....
Via
Benzinga
Market Briefing For Wednesday, Aug. 4
August 04, 2021
'Subject to mandate' seems to be a catch-phrase these days; mandates to fly, to eat, to drink in a pub, to go to a show, and even to govern New York (of course that last one was an effort at humor,...
Via
Talk Markets
Market Briefing For Tuesday, Aug. 3
August 03, 2021
We do see Tuesday turnaround as a rebound from Monday's just modest fade. Again our wildcard continues to be Covid; and the 'presumed' dovish Fed as relates to 'tapering'.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Sorrento Therapeutics To Start Testing DAR-T Cell Therapy In Multiple Myeloma Patients
August 02, 2021
The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ: SRNE) IND application for the Phase 1 clinical testing of its allogeneic anti-CD38 Dimeric Antigen...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.